| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.32 | 1e-18 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.33 | 1e-18 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.31 | 1e-17 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.26 | 4e-15 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.26 | 5e-14 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.23 | 7e-14 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.26 | 7e-14 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.24 | 2e-13 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.28 | 2e-13 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.22 | 2e-13 |